跳至主要内容
临床试验/NCT01613547
NCT01613547已完成不适用

The Effect of Routine Antibiotic Use in the Outpatient Treatment of Severely Malnourished Children Without Complications: Maradi, Niger

Epicentre1 个研究点 分布在 1 个国家目标入组 2,412 人开始时间: 2012年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
Epicentre
入组人数
2,412
试验地点
1
主要终点
Proportion of children discharged from nutritional program as recovered

研究概览

简要总结

This study will be conducted as a randomized, double-blind, placebo-controlled trial to compare routine antibiotic prescription vs. no routine antibiotic prescription in the management of uncomplicated cases of severe acute malnutrition treated in the community in terms of nutritional recovery. The investigators hypothesize that there will be no significant difference in terms of the risk of nutritional recovery among children uncomplicated cases of severe acute malnutrition treated in the community that receive routine antibiotic prescription and those who receive no routine antibiotic prescription.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
6 Months 至 59 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Age from 6 to 59 months
  • MUAC < 11.5 cm or WHZ < -3
  • Absence of bipedal edema
  • Absence of current illness requiring inpatient care
  • Eligible for new admission for outpatient nutritional therapy for SAM at 3 CRENAS in Madarounfa operated by FORSANI
  • Absence of current clinical illness requiring prescription of specific antibiotic therapy and decision by the study physician to use a specific antimicrobial drug on admission
  • Written consent of parent or caregiver
  • Residence within Niger

排除标准

  • Age < 6 months or > 59 months
  • MUAC ≥ 11.5 cm and WHZ ≥ -3
  • Presence of bipedal edema
  • Presence of current illness requiring inpatient care
  • Decision by the study physician to use a specific different antimicrobial drug on admission
  • Presence of any congenital abnormality or underlying chronic disease that may affect growth or risk of infection
  • Treatment with any antibiotic within 7 days
  • Admission to any nutritional program for the treatment of SAM within 3 months
  • Known contraindication / hypersensitivity to amoxicillin

研究组 & 干预措施

Routine antibiotic prescription

Active Comparator

Routine antibiotic prescription with amoxicillin (80 mg/kg/day for 7 days)

干预措施: Amoxicillin (Drug)

No routine antibiotic prescription

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Proportion of children discharged from nutritional program as recovered

时间窗: Until discharge from the nutritional program, an expected average of 5 weeks

次要结局

  • Hospitalization or death(3 months following enrollment)

研究者

发起方
Epicentre
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sheila Isanaka

Prinicipal Investigator

Epicentre

研究点 (1)

Loading locations...

相似试验